ALEXANDRIA, Va., Aug. 5 -- United States Patent no. 12,697,312, issued on Aug. 4.
"Methods and devices for treatment of eyelid ptosis" was invented by Atif B. D. Collins (Fresno, Calif.).
According to the abstract* released by the U.S. Patent & Trademark Office: "Provided herein is a drug eluting device that can be implanted into the Muller's muscle of a subject to elute a sympathetic stimulant such as oxymetazoline, phenylephrine, norepinephrine, adrenaline, or a combination thereof. Also provided herein are methods to use the device and sympathetic stimulant to treat or prevent eyelid ptosis."
The patent was filed on Oct. 2, 2023, under Application No. 18/479,520.
*For further information, including images, charts and tables, please v...